InnovAge Holding Corp. Announces Increase of Share Repurchase Program

Published on September 26, 2024

DENVER, Sept. 26, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (NASDAQ: INNV) (the “Company” or “InnovAge”) announced today that its Board of Directors has increased the amount of its common stock that may be repurchased under its share repurchase program (the “Program”), originally approved in

Continue reading on website
Other news

AbZelectPRO™ enables biopharma customers to reach their research cell bank in 10 weeks with 8g/L

September 26, 2024
San Diego, CA – September 26, 2024 – Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced that its mammalian cell line development platform, AbZelectPRO™, has significantly reduced its timelines by >30% and improved its overall protein production levels. The platform now offers biopharma customers the ability to bridge from DNA to research cell bank

Pharmaceutical Technology: Forging Ahead in Formulation

September 26, 2024
Abzena’s Senior Manager in Analytics, Gary Watts is featured in the latest edition of Pharmaceutical Technology. As part of the articles ‘Forging Ahead in Formulation’ feature, Gary discusses how new and existing technologies, as well as a patient centric focus, are moving drug formulation into exciting directions.There are a variety of factors pushing the innovation in formulation of drug product